• Sowmiya Kalaiselvan
  • Mahaboobkhan Rasool


Objective:The present investigation was carried out to assess the protective properties of Spirulina fusiformis against galactosamine induced toxicity in swiss albino mice. Methods:Evaluation of serum glutamate oxaloacetate transferase (SGOT), serum glutamate pyruvate transferase (SGPT), alkaline phosphatase (ALP), serum bilirubin (SBLN), antioxidant status and TNF-α was done and was compared with the standard reference drug silymarin.

Results: Galactosamine injection significantly increased the levels of SGOT, SGPT, SBLN and TNF–α in the serum and caused depletion in the antioxidant status in the liver. Administration of Spirulina fusiformis altered these parameters and brought them to normal levels in the control and experimental mice.

Conclusion:Hence results of this study clearly indicate that Spirulina fusiformis has hepatoprotective activity against galactosamine induced toxicity in mice.

Keywords: Spirulina, antioxidant, galactosamine, hepatoprotective, silymarin


1. Keppler D, Decker K. Studies on the mechanism of galactosamine hepatitis: accumulation of galactosamine-1-phosphate and its inhibition of UDP-glucose pyrophosphorylase. Eur J Biochem 1969;10: 219–225.
2. Mangeney-Andreani M, Sire O,Montagne-Clavel J, Nordmann R, Nordmann J. Inhibitory effect of D-galactosamine administration on fatty oxidation in rat hepatocytes. FEBS Lett. 1982; 145: 267-270.
3. Mendes RF, Nobre BP, Cardoso MT, Peveira A, Palavra AF.Supercritical carbon dioxide extraction of compounds with pharmaceutical importance from microalgae. Inorganica Chem. Acta 2005; 356:328-334.
4. Hsiao G, Chou PH, Shen MY, Chou DS, Lin Ch, Cheu JR. C-Phycocyanin, a very potent and novel platelet aggregation inhibitor from Spirulina platensis. J. Agric. Food Chem. 2005; 53 Suppl 20: 7734– 7740.
5. Khan M, Shobha JC, Mohan IK, Naidu MU, Sundaram C, Singh S, et al. Effect of Spirulina against doxorubicin-reduced cardiotoxicity. Phytother. Res. 2005a;19 (12): 1030–1037.
6. Khan M, Varadhara S, Gansesa LP, Shobha JC, Naidu MU, Parmandi NL , et al. C-phycocyanin protects against ischemia-reperfusion injury of heart through involvement of p38 and ERK signaling. Am. J. Physiol. Heart Circ. Physiol. 2005b; 290 Suppl 5: H2136–H2145.
7. Teas J, Herbert JR, Fitton JH, Zimba PV. Algae – A poor man’s HAART? Medical Hypotheses 2004;62 Suppl 4: 507–510.
8. Herna´ndez-Corona A, Meckes M, Chamorro G, Barron ML.Antiviral activity of Spirulina maxima against herpes simplex virus type 2. Antivir. Res. 2002;56 Suppl 3: 279–285.
9. Ozdemir G, Karabay NU, Dalay M, Pazarbasi B. Antibacterial activity of volatile component and various extracts of Spirulina platensis. Phytother. Res. 2004; 18 Suppl 9: 754–757.
10. Nagaoka S, Shimizu K, Kaneko H, Shibayama F, Morikawa K, Kanamaru Y,et al. A novel protein C-phycocyanin plays a crucial role in the hypocholesterolemic action of Spirulina platensis concentrate in rats. J. Nutr. 2005; 135 Suppl 10: 2425–2430.
11. Khan M, Shobha JC, Mohan IK, Rao Naidu MU, Prayag A, Kutala VK. Spirulina attenuates cyclosporine-induced nephrotoxicity in rats. J. Appl. Toxicol. 2006; 26 Suppl 5: 444–451.
12. Haque SE, Gilani KM. Effect of ambroxol, Spirulina and vitamin-E in naphtalene induced cataract in female rats. Indian J. Physiol. Pharmacol. 2005;49 Suppl 1: 57–64.
13. Mao K, Van de Water J, Gershwin ME. Effects of Spirulina based dietary supplement on cytokine production from allergic rhinitis patients. J. Med. Food 2005; 28 Suppl 1: 27–30.
14. Mascher D, Paredes-Carvajal MC, Torres-Dura´n PV, Zamora- Gonza´lez J, Dı´az-Zagoya JC, Jua´rez-Oropeza MA. Ethanolic extract of Spirulina maxima alters the vasomotor reactivity of aortic rings form obese rats. Arch. Med. Res. 2005; 37 Suppl 1: 50–57.
15. Jeyaprakash K, Chinnaswamy P. Effect of Spirulina and Liv-52 on cadmium induced toxicity in albino rats. Indian J. Exp. Biol. 2005; 43: 773–781.
16. Saha SK, Misbahuddin M, Khatu R, Mammum IR. Effect of hexane extract of Spirulina in the removal of arsenic form isolated liver tissues of rat. Mymensingh. Med. J. 2005; 14 Suppl 2: 191–195.
17. King J.The transferases alanine and aspartate transaminases, In: Practical clinical enzymology,Van D.(Ed),Nostrand,London;1965a, p.121-138.
18. King J. The hydrolases – acid and alkaline phosphatases.In: Practical clinical enzymology, Van D.(Ed),Nostrand,London ;1965b, p. 191-208.
19. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem; 95:351-8.
20. Marklund SL ,Marklund G. Involvement of superoxide anion radical in the autooxidation of pyrogallol and a convienient assay for superoxide dismutase. Eur. J. Biochem. 1972; 47 :469-474.
21. Sinha AK. Colorimetric assay of Catalase. Anal Biochem. 1872; 47:389-394.
22. Bellomo G, Mirabelli F, Dimonte D, Richelmi P, Thor H, Orrenius C et al. Formation and reduction of glutathione-mixed disulphides during oxidative stress. Biochem. Pharmacol. 1987; 36: 1313-1320.
23. Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione-s-transferase activities in rat lung and liver. Biochim. Biophys. Acta.1979; 582:67-78.
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein Measurement with the Folin Phenol Reagent. J Biol Chem 1951; 193:265-275.
25. Keppler D, Lesch R, Reutter W, Decker K. Experimental hepatitis induced by D galactosamine.Exp Mol Pathol. 1968; 9 Suppl 2: 279–290.
26. Mitra SK, Venkataranganna MV, Sundaram R, Gopumadhavan S. Protective effect of HD-03, a herbal formulation, against various hepatotoxic agents in rats. Journal of Ethnopharmacology 1998; 63: 181–186.
27. Martin P, Friedman LS. Assessment of liver function and diagnostic studies. In: Friedman LS, Keefe EB, editors. Handbook of liver disease. Churchill Livingston: Harcourt Brace Co; 1998. p. 1-14.
28. Sree Ramamurthy M, Srinivasan M. Hepatoprotective effect of Tephrosia Purpurcea in experimental animals. Indian J Pharmacol 1993; 25:34-36.
29. Maezona K, Mawatari K, Kajiwara K, Shinkai A, Maki T. Effect of Alanine on d-galactosamine induced acute liver failure in rats. Hepatology 1996; 24:1211-1216.
30. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J.Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39:44–84.
31. Wang BJ, Liu CT, Tseng CY, Wu CP, Yu ZR.Hepatoprotective and antioxidant effects of Bupleurum kaoi Liu (Chao et Chuang) extract and its fractions fractionated using supercritical CO2 on CCl4-induced liver damage. Food Chem Toxicol 2004; 42:609–617.
32. Reiter RJ, Tan D, Osuna C, Gitto E.Actions of melatonin in the reduction of oxidative stress. A review. J Biomed. Sci.2000; 7:444–458.
33. Chang Y, Hsiao G, Chen SH, Chen YC, Lin JH, Lin KH, et al. Tetramethylpyrazine suppresses HIF-1alpha, TNF-alpha, and activated caspase-3 expression in middle cerebral artery occlusion-induced brain ischemia in rats.Acta Pharmacol Sin.2007;28 Suppl 3:327-33.
412 Views | 346 Downloads
How to Cite
VEDI, M., S. Kalaiselvan, M. Rasool, and E. PRINCE SABINA. “PROTECTIVE EFFECTS OF BLUE GREEN ALGAE SPIRULINA FUSIFORMIS AGAINST GALACTOSAMINE-INDUCED HEPATOTOXICITY IN MICE”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 6, no. 7, Aug. 2013, pp. 150-4,